Evidence map›Paper›PMID 38610639›Full record

ArticleJournal of clinical medicine2024

Is Metformin Use Associated with a More Favorable COVID-19 Course in People with Diabetes?

Giovanni Antonio Silverii, Carlo Fumagalli, Renzo Rozzini, Marta Milani, Edoardo Mannucci, Niccolò Marchionni

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Giovanni Antonio SilveriiExperimental and Clinical Biomedical Sciences "Mario Serio" Department, University of Florence, 50134 Florence, Italy.ORCID 0000-0002-6695-3213
Carlo FumagalliDepartment of Advanced Medical and Surgical Sciences, Università degli Studi della Campania "Luigi Vanvitelli", 80138 Naples, Italy.ORCID 0000-0001-7963-5049
Renzo RozziniDepartment of Internal Medicine and Geriatrics, Fondazione Poliambulanza Istituto Ospedaliero, 25124 Brescia, Italy.
Marta MilaniExperimental and Clinical Biomedical Sciences "Mario Serio" Department, University of Florence, 50134 Florence, Italy.
Edoardo MannucciExperimental and Clinical Biomedical Sciences "Mario Serio" Department, University of Florence, 50134 Florence, Italy.
Niccolò MarchionniExperimental and Clinical Medicine Department, University of Florence, 50134 Florence, Italy.
University of Florence · ITFondazione Poliambulanza Istituto Ospedaliero · ITUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 mortalityCOVID-19 MRSDiabetes Mellitusmetformin

Identifiers

PMID38610639
PMCPMC11012895
OpenAlexW4393142663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.